Full Text View
Tabular View
Study Results
Related Studies
Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout
This study has been completed.
Study NCT00174967   Information provided by Takeda Global Research & Development Center, Inc.
First Received: September 9, 2005   Last Updated: August 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Gout
More general conditions related to this trial
Arthritis
Genetic Diseases, Inborn
Joint Diseases
Metabolic Diseases
Metabolism, Inborn Errors
Musculoskeletal Diseases
Purine-Pyrimidine Metabolism, Inborn Errors
Rheumatic Diseases
Interventions listed in this trial
Placebo
Febuxostat
More general drug interventions related to this trial
Antirheumatic Agents
Gout Suppressants
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Takeda Global Research &Development Center, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services